Form 144 RxSight, Inc. Filed by: Goldshleger Ilya
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
RxSight Inc. (RXST) PT Lowered to $65 at Stifel
August 6, 2024 5:17 AM EDTStifel analyst Tom Stephan lowered the price target on RxSight Inc. (NASDAQ: RXST) to $65.00 (from $70.00) while maintaining a Buy rating.
The analyst comments "RXST shares should snap back from an inexplicably-pronounced intra-quarter sell-off--likely exasperated by a difficult med-tech tape--following a strong beat-and-raise. While... More
RxSight Inc. (RXST) PT Lowered to $59 at BTIG
August 6, 2024 4:57 AM EDTBTIG analyst Ryan Zimmerman lowered the price target on RxSight Inc. (NASDAQ: RXST) to $59.00 (from $73.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and adjust our PT to $59 (from $73) following 2Q24 results. RXST continues to deliver strong FY24 results with 2Q24 revenue of $34.9M (67.6% Y/Y) and adj. LPS of $0.00 above BTIG/Consensus ests. of $32.2M/$32.3M and adj. LPS of... More
